Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 14 studies | 30% ± 13% | |
goblet cell | 9 studies | 35% ± 19% | |
epithelial cell | 9 studies | 42% ± 16% | |
secretory cell | 6 studies | 29% ± 11% | |
basal cell | 6 studies | 35% ± 12% | |
respiratory goblet cell | 3 studies | 18% ± 1% | |
squamous epithelial cell | 3 studies | 37% ± 23% | |
mucus secreting cell | 3 studies | 29% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 33% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1892.09 | 328 / 328 | 96% | 61.20 | 170 / 178 |
lung | 98% | 1065.75 | 565 / 578 | 95% | 53.55 | 1099 / 1155 |
prostate | 92% | 1272.07 | 226 / 245 | 98% | 72.47 | 493 / 502 |
thymus | 100% | 1861.24 | 653 / 653 | 86% | 36.21 | 519 / 605 |
stomach | 77% | 2308.29 | 276 / 359 | 97% | 67.38 | 278 / 286 |
ovary | 69% | 461.83 | 125 / 180 | 96% | 43.69 | 414 / 430 |
intestine | 53% | 1330.15 | 513 / 966 | 98% | 77.89 | 517 / 527 |
breast | 70% | 967.90 | 320 / 459 | 77% | 35.68 | 858 / 1118 |
esophagus | 45% | 1207.85 | 657 / 1445 | 98% | 79.06 | 180 / 183 |
bladder | 52% | 507.71 | 11 / 21 | 90% | 45.10 | 454 / 504 |
skin | 74% | 771.06 | 1335 / 1809 | 50% | 11.23 | 234 / 472 |
kidney | 96% | 758.83 | 85 / 89 | 14% | 3.16 | 128 / 901 |
uterus | 20% | 143.95 | 34 / 170 | 81% | 44.14 | 372 / 459 |
spleen | 100% | 1946.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 32.47 | 40 / 45 |
peripheral blood | 84% | 913.16 | 777 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 23.91 | 58 / 80 |
adrenal gland | 47% | 156.81 | 121 / 258 | 0% | 0.05 | 1 / 230 |
adipose | 30% | 102.59 | 364 / 1204 | 0% | 0 | 0 / 0 |
liver | 18% | 61.28 | 41 / 226 | 9% | 3.92 | 36 / 406 |
brain | 20% | 76.25 | 529 / 2642 | 3% | 0.53 | 23 / 705 |
blood vessel | 17% | 67.63 | 223 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 1.27 | 4 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.45 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016266 | Biological process | O-glycan processing |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0007283 | Biological process | spermatogenesis |
GO_0018243 | Biological process | protein O-linked glycosylation via threonine |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0018242 | Biological process | protein O-linked glycosylation via serine |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0030145 | Molecular function | manganese ion binding |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030246 | Molecular function | carbohydrate binding |
Gene name | GALNT3 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3) Polypeptide N-acetylgalactosaminyltransferase 3 |
Synonyms | |
Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor . Has activity toward HIV envelope glycoprotein gp120, EA2, MUC2, MUC1A and MUC5AC . Probably glycosylates fibronectin in vivo . Glycosylates FGF23 . . |
Accessions | C9J2C3 ENST00000431484.1 C9J388 ENST00000409882.5 C9JW45 ENST00000422973.1 ENST00000412248.5 C9JY57 H7BZS4 Q14435 ENST00000447156.1 E7EUL0 ENST00000437849.1 Q68VJ6 ENST00000414977.5 ENST00000392701.8 [Q14435-1] C9JXX2 |